Autonomous CEO, Dr. Ariel Weinberger, serves on keynote panel at World Vaccine & Immunotherapy Congress

Written by Ariel Weinberger

The panel titled “Platforms of the future: from precision therapies to synthetic immune systems” was moderated by Bloomberg healthcare reporter Riley Ray Griffin and included experts from Andreessen Horowitz, Moderna, and the U.S. Military in addition to Autonomous Therapeutics.

Ariel Weinberger
Previous

Autonomous Therapeutics and Mink Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors
Next

Autonomous CEO, Dr. Ariel Weinberger, gives plenary presentation at NIH Synthetic Biology Consortium Meeting